SCHEMBL6760481

SCHEMBL6760481

CC(C)C(CN)C(c1ccccc1)(c1cc(CO)ccc1OC(=O)c1ccccc1)C(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.36
TDP1 Q9NUW8 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
HPGD P15428 4/20 0.35
CHRM2 P08172 1/20 0.34
CHRM1 P11229 1/20 0.34
ELANE P08246 1/20 0.33
MAPT P10636 3/20 0.33
SLC6A3 Q01959 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
USP2 O75604 2/20 0.32
NR1I2 O75469 1/20 0.32
ADRB1 P08588 1/20 0.32
HTR1A P08908 1/20 0.32
ADRA2A P08913 1/20 0.32
ADORA3 P0DMS8 1/20 0.32
ADRA2B P18089 1/20 0.32
ADRA2C P18825 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6757095 0.80 KIF11 (0.34) CYP3A4TDP1KMT2AMEN1HPGD
SCHEMBL6760704 0.68 CHRM3 (0.30) CHRM3
SCHEMBL6760480 0.67 CHRM2 (0.51) CYP3A4TDP1L3MBTL1KMT2AMEN1
SCHEMBL16610045 0.67 KMT2A (0.71) CYP3A4TDP1L3MBTL1KMT2AMEN1
SCHEMBL3236453 0.67 HPGD (0.50) CYP3A4TDP1L3MBTL1KMT2AMEN1
Benzamide SCHEMBL21771943 0.64 PARP10 (0.48) CYP3A4TDP1L3MBTL1KMT2AMEN1
SCHEMBL20429147 0.63 KMT2A (0.43) CYP3A4TDP1L3MBTL1KMT2AMEN1
SCHEMBL8844966 0.62 TDP1 (0.60) CYP3A4TDP1L3MBTL1KMT2AMEN1
SCHEMBL2507768 0.62 ALOX15 (0.56) CYP3A4TDP1L3MBTL1KMT2AMEN1
SCHEMBL16166369 0.62 CHRM2 (0.52) KMT2AMEN1CHRM2CHRM1ELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8338478-B2 Derivatives of 3,3-diphenylpropylamines UCB PHARMA GMBH (DE) 2012-12-25 US disclosed
US-20040186061-A1 Novel derivatives of 3,3-diphenylpropylamines SCHWARZ PHARMA AG 2004-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040186061-A1 Novel derivatives of 3,3-diphenylpropylamines ADRB3, ADRA1D, TNNC1 CYP3A4 137/4885TDP1 459/4885L3MBTL1 4023/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.